Search research articles
Contact Us
Filters
Showing results (251-260 of 1,134) with videos related to
Page
of 114
Sort By:
Diagnosis (Berlin, Germany)
|
October 11, 2023
Tumor heterogeneity: how could we use it to achieve better clinical outcomes?
Arsani Yousef, Lucianna Ghobrial, Eleftherios P Diamandis
Clinical Chemistry and Laboratory Medicine
|
March 17, 2021
Assay requirements for COVID-19 testing: serology vs. rapid antigen tests
Ioannis Prassas, Clare Fiala, Eleftherios P Diamandis
Diagnosis (Berlin, Germany)
|
September 8, 2021
From the amyloid hypothesis to the autoimmune hypothesis of Alzheimer's disease
Bryant Lim, Ioannis Prassas, Eleftherios P Diamandis
NPJ Precision Oncology
|
June 7, 2018
Towards personalized tumor markers
Vathany Kulasingam, Ioannis Prassas, Eleftherios P Diamandis
Cancer Letters
|
February 6, 2007
Human tissue kallikreins: the cancer biomarker family
Miltiadis Paliouras, Carla Borgono, Eleftherios P Diamandis
International Journal of Cancer
|
January 6, 1997
Humoral immune response against p53 protein in patients with colorectal carcinoma
K Angelopoulou, M Stratis, E P Diamandis
Clinical Biochemistry
|
January 7, 1999
A candidate new gene on human chromosome 5q12 contains a motif that is found in transcriptional co-activators
K Angelopoulou, C Prody, E P Diamandis
Analytical Chemistry
|
January 15, 1993
Quantification of polymerase chain reaction products in agarose gels with a fluorescent europium chelate as label and time-resolved fluorescence spectroscopy
A Chan, E P Diamandis, M Krajden
Biological Chemistry
|
May 24, 2014
Putative kallikrein substrates and their (patho)biological functions
Yijing Yu, Ioannis Prassas, Eleftherios P Diamandis
Clinical Chemistry and Laboratory Medicine
|
March 27, 2019
Benefits and harms of wellness initiatives
Clare Fiala, Jennifer Taher, Eleftherios P Diamandis
Page
of 114
Search research articles
Search
Showing results (251-260 of 1,134) with videos related to
Sort By:
Page
of 114
Diagnosis (Berlin, Germany)
|
October 11, 2023
Tumor heterogeneity: how could we use it to achieve better clinical outcomes?
Arsani Yousef, Lucianna Ghobrial, Eleftherios P Diamandis
Clinical Chemistry and Laboratory Medicine
|
March 17, 2021
Assay requirements for COVID-19 testing: serology vs. rapid antigen tests
Ioannis Prassas, Clare Fiala, Eleftherios P Diamandis
Diagnosis (Berlin, Germany)
|
September 8, 2021
From the amyloid hypothesis to the autoimmune hypothesis of Alzheimer's disease
Bryant Lim, Ioannis Prassas, Eleftherios P Diamandis
NPJ Precision Oncology
|
June 7, 2018
Towards personalized tumor markers
Vathany Kulasingam, Ioannis Prassas, Eleftherios P Diamandis
Cancer Letters
|
February 6, 2007
Human tissue kallikreins: the cancer biomarker family
Miltiadis Paliouras, Carla Borgono, Eleftherios P Diamandis
International Journal of Cancer
|
January 6, 1997
Humoral immune response against p53 protein in patients with colorectal carcinoma
K Angelopoulou, M Stratis, E P Diamandis
Clinical Biochemistry
|
January 7, 1999
A candidate new gene on human chromosome 5q12 contains a motif that is found in transcriptional co-activators
K Angelopoulou, C Prody, E P Diamandis
Analytical Chemistry
|
January 15, 1993
Quantification of polymerase chain reaction products in agarose gels with a fluorescent europium chelate as label and time-resolved fluorescence spectroscopy
A Chan, E P Diamandis, M Krajden
Biological Chemistry
|
May 24, 2014
Putative kallikrein substrates and their (patho)biological functions
Yijing Yu, Ioannis Prassas, Eleftherios P Diamandis
Clinical Chemistry and Laboratory Medicine
|
March 27, 2019
Benefits and harms of wellness initiatives
Clare Fiala, Jennifer Taher, Eleftherios P Diamandis
Page
of 114